Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case-control study.


Journal

Breast cancer (Tokyo, Japan)
ISSN: 1880-4233
Titre abrégé: Breast Cancer
Pays: Japan
ID NLM: 100888201

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 06 09 2019
accepted: 25 02 2020
pubmed: 8 3 2020
medline: 12 1 2021
entrez: 8 3 2020
Statut: ppublish

Résumé

There is convincing evidence demonstrating that body size characteristics such as adiposity and height are associated with breast cancer in westernized countries. However, little is known about this relationship in North African countries currently undergoing nutritional transition and industrialization. The aim of this study was to explore associations between various body size characteristics, silhouette trajectories and the risk of breast cancer among Moroccan women. In this case-control study conducted in the Fez region (2016-2017), detailed measures of body size were collected for 300 cases of breast cancer and 300 matched controls. Unconditional logistic regression was used to assess the association between body size and breast cancer risk adjusting for confounding factors. Higher waist circumference and hip circumference were positively associated with breast cancer risk in pre- (highest [T3] vs. lowest tertile [T1]: OR = 2.92, 95% confidence intervals [CI]: 1.33-6.42; OR = 3.00, 95% CI: 1.42-6.33, respectively) and post-menopausal women (T3 vs. T1: OR = 4.46, 95% CI: 1.86-10.66; OR = 4.08, 95% CI: 1.76-9.42, respectively). Body shape at younger ages (6-11 years) was inversely associated with the risk of breast cancer in premenopausal women (large vs. lean silhouette: OR = 0.31, 95% CI: 0.12-0.80). Women with the greatest increase in body shape trajectory had higher risk for both pre- and post-menopausal breast cancer (T3 vs. T1: OR = 2.74, 95% CI: 1.03-7.26; OR = 3.56, 95% CI: 1.34-9.44, respectively). Our findings suggest that adiposity, body shape at younger ages, and silhouette trajectory may play a role in the development of pre- and post-menopausal breast cancer among Moroccan women. Larger-scale prospective studies are needed to confirm our findings and to explore these associations with breast cancer subtypes.

Sections du résumé

BACKGROUND BACKGROUND
There is convincing evidence demonstrating that body size characteristics such as adiposity and height are associated with breast cancer in westernized countries. However, little is known about this relationship in North African countries currently undergoing nutritional transition and industrialization. The aim of this study was to explore associations between various body size characteristics, silhouette trajectories and the risk of breast cancer among Moroccan women.
METHODS METHODS
In this case-control study conducted in the Fez region (2016-2017), detailed measures of body size were collected for 300 cases of breast cancer and 300 matched controls. Unconditional logistic regression was used to assess the association between body size and breast cancer risk adjusting for confounding factors.
RESULTS RESULTS
Higher waist circumference and hip circumference were positively associated with breast cancer risk in pre- (highest [T3] vs. lowest tertile [T1]: OR = 2.92, 95% confidence intervals [CI]: 1.33-6.42; OR = 3.00, 95% CI: 1.42-6.33, respectively) and post-menopausal women (T3 vs. T1: OR = 4.46, 95% CI: 1.86-10.66; OR = 4.08, 95% CI: 1.76-9.42, respectively). Body shape at younger ages (6-11 years) was inversely associated with the risk of breast cancer in premenopausal women (large vs. lean silhouette: OR = 0.31, 95% CI: 0.12-0.80). Women with the greatest increase in body shape trajectory had higher risk for both pre- and post-menopausal breast cancer (T3 vs. T1: OR = 2.74, 95% CI: 1.03-7.26; OR = 3.56, 95% CI: 1.34-9.44, respectively).
CONCLUSION CONCLUSIONS
Our findings suggest that adiposity, body shape at younger ages, and silhouette trajectory may play a role in the development of pre- and post-menopausal breast cancer among Moroccan women. Larger-scale prospective studies are needed to confirm our findings and to explore these associations with breast cancer subtypes.

Identifiants

pubmed: 32144737
doi: 10.1007/s12282-020-01072-5
pii: 10.1007/s12282-020-01072-5
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

748-758

Subventions

Organisme : Moffitt Cancer Center
ID : 5D43TW009804

Auteurs

Mohamed Khalis (M)

School of Public Health, Mohammed VI University of Health Sciences, Anfa City : Bld Mohammed Taïeb Naciri, Hay Hassani, 82 403, Casablanca, Morocco. mkhalis@um6ss.ma.
UCBL, Ifsttar, UMRESTTE, University of Lyon, Lyon, France. mkhalis@um6ss.ma.

Laure Dossus (L)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Sabina Rinaldi (S)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Carine Biessy (C)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Aurélie Moskal (A)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Hafida Charaka (H)

Department of Research and Development, Hassan II University Hospital of Fez, Fez, Morocco.

Emmanuel Fort (E)

UCBL, Ifsttar, UMRESTTE, University of Lyon, Lyon, France.

Mathilde His (M)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Nawfel Mellas (N)

Department of Oncology, Hassan II University Hospital of Fez, Fez, Morocco.

Chakib Nejjari (C)

School of Public Health, Mohammed VI University of Health Sciences, Anfa City : Bld Mohammed Taïeb Naciri, Hay Hassani, 82 403, Casablanca, Morocco.

Barbara Charbotel (B)

UCBL, Ifsttar, UMRESTTE, University of Lyon, Lyon, France.

Amr S Soliman (AS)

Department of Community Health and Social Medicine, School of Medicine, City University of New York, New York, USA.

Isabelle Romieu (I)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Véronique Chajès (V)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Marc J Gunter (MJ)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Inge Huybrechts (I)

Nutrition and Metabolism Section, International Agency for Research On Cancer, Lyon, France.

Karima El Rhazi (K)

Department of Epidemiology, Faculty of Medicine and Pharmacy, Fez, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH